4 Ways AI Transforms Clinical Operations: From Data Oversight to Risk Management
4 Ways AI Transforms Clinical Operations: From Data Oversight to Risk Management
Clinical Operations teams face mounting pressure to manage growing data complexity, ensure regulatory compliance, and mitigate risks—all while meeting tight timelines. Traditional methods often lead to inefficiencies, fragmented oversight, and delayed insights.
In this exclusive webinar, discover how DTect AI, an innovative AI-powered platform, helps life sciences organizations optimize clinical trial data quality management. DTect AI transforms Integrated Data Review (IDR) and Risk-Based Quality Management (RBQM) processes ensuring and unmatched data integrity and significantly reducing data management cycle times.
Why Attend This Webinar?
You will learn about the impact of DTect AI on the clinical data value chain and see a live demo Discover how DTect AI revolutionizes Clinical Operations, Data Management, Safety, and Medical Monitoring, enhancing data quality and accelerating decision-making processes. Through real-world case studies and expert insights, you’ll gain a comprehensive understanding of DTect AI’s critical role in clinical trials and how it helps organizations achieve their goals effectively.
Key Learnings:
- Review major limitations of traditional data management and risk monitoring methods.
- Learn how AI-powered platforms like DTect AI transform traditional data review processes, with focus on automated anomaly detection and real-time data quality monitoring.
- Leverage AI analytics to optimize site performance metrics and protocol compliance while reducing data review cycles.
- Harness data potential through sophisticated actionable insights that go further than basic dashboards.
- Explore case studies and experience a live demo showcasing how Clinical Operations teams can leverage AI-driven insights to enhance efficiency and accuracy.
What Makes DTect AI Stand Out?
- Outperforming Traditional Methods: DTect AI uses AI to automate data reviews, integrate diverse datasets, detect anomalies in real time, and deliver actionable insights—making it a strategic enabler of clinical trial success.
- Regulatory Compliance: Adhering to FDA and ICH guidelines, DTect AI accelerates results delivery to research teams, facilitating timely issue resolution.
- Advanced RBQM Capabilities: Serves as a catalyst for Risk-Based Quality Management (RBQM) by identifying real-time outliers, providing prescriptive and actionable oversight of risk factors, and monitoring QTL performance through adaptive and intelligent analytics.
- Leveraging Advanced Technologies: DTect AI integrates statistical models, AI, and machine learning algorithms to analyze collected data, ensuring consistency and avoiding biased or erroneous outcomes.
Register now to join an interactive session and empower yourself and your team for greater efficiency and success!
Speakers

Varsha Kishore
Product Management Leader, Maxis AI
Varsha Kishore Product Management Leader·Maxis AI Varsha Kishore is a strategic Product Management Leader at MaxisIT, where she spearheads the conceptualization and end-to-end delivery of flagship Agentic AI products. With over ten years of experience in clinical IT and Pharmaceutical industry, she has evolved from a high-impact Business Analyst into a visionary leader specializing in the integration of AI frameworks within GxP-compliant clinical trials. Varsha is recognized for orchestrating high-performing cross-functional teams to drive innovation and operational excellence.

Dr. Rachna Saralkar
Product Management Leader, Maxis AI
Dr. Rachna Saralkar is a double board-certified physician and Principal Investigator at Flourish Research, specializing in psychiatry, clinical informatics, and the application of AI in healthcare. She brings deep expertise at the intersection of clinical research, digital health, and emerging technologies, with a focus on advancing more efficient and patient-centered clinical development. Previously, she served as Medical Product Director at Deliberate AI, where she led the development of AI-enabled solutions for mental healthcare. She has also advised several early-stage health technology startups as a fractional Chief Medical Officer. Dr. Saralkar completed her psychiatry residency at Johns Hopkins University and holds a Master’s in Clinical Informatics Management from Stanford University School of Medicine.

